BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23721166)

  • 1. Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.
    Sekiduka-Kumano T; Kawayama T; Ito K; Shoji Y; Matsunaga K; Okamoto M; Edakuni N; Imaoka H; Uchimura N; Hoshino T
    BMC Psychiatry; 2013 May; 13():159. PubMed ID: 23721166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients.
    Mitani H; Shirayama Y; Yamada T; Kawahara R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):531-4. PubMed ID: 16414168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients.
    Markianos M; Alevizos B; Hatzimanolis J; Stefanis C
    Psychiatry Res; 1994 Jun; 52(3):259-64. PubMed ID: 7527564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
    Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
    Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
    Soda E; Miura I; Hoshino H; Kanno-Nozaki K; Ota T; Oguchi H; Watanabe K; Yang Q; Mashiko H; Niwa S
    Psychiatry Res; 2014 Dec; 220(1-2):639-45. PubMed ID: 25200191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
    Watanabe K; Miura I; Kanno-Nozaki K; Horikoshi S; Mashiko H; Niwa S; Yabe H
    Psychiatry Res; 2015 Dec; 230(2):419-23. PubMed ID: 26416588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis.
    Devanand DP; Bowers MB; Hoffman FJ; Nelson JC
    Psychiatry Res; 1985 May; 15(1):1-4. PubMed ID: 3859880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenic amine metabolites in delusional (psychotic) depression and melancholia subtypes of major depression.
    Lykouras L; Markianos M; Hatzimanolis J; Malliaras D; Stefanis C
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1261-71. PubMed ID: 7532316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y; Bardgett ME; Csernansky JG
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
    Markianos M; Botsis A; Arvanitis Y
    Biol Psychiatry; 1992 Aug; 32(3):288-92. PubMed ID: 1384728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
    Heinz A; Weingartner H; George D; Hommer D; Wolkowitz OM; Linnoila M
    Psychiatry Res; 1999 Dec; 89(2):97-106. PubMed ID: 10646828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical variables in delusional depression.
    Lykouras E; Markianos M; Malliaras D; Stefanis C
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms, monoamines levels, MAO-B activity and effect of treatment in a subset of depressed individuals from government sector hospital at Karachi.
    Zeb F; Naqvi S; Rahman R; Farooq AD
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1509-1519. PubMed ID: 29044007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J; Lykouras L; Markianos M; Oulis P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.